Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS

Neurology
J MasjuanLuisa M Villar

Abstract

Patients with a clinically isolated demyelinating syndrome (CIS) are at risk of developing a second attack, thus converting into clinically definite multiple sclerosis (CDMS). Therefore, an accurate prognostic marker for that conversion might allow early treatment. Brain MRI and oligoclonal IgG band (OCGB) detection are the most frequent paraclinical tests used in MS diagnosis. A new OCGB test has shown high sensitivity and specificity in differential diagnosis of MS. To evaluate the accuracy of the new OCGB method and of current MRI criteria (MRI-C) to predict conversion of CIS to CDMS. Fifty-two patients with CIS were studied with OCGB detection and brain MRI, and followed up for 6 years. The sensitivity and specificity of both methods to predict conversion to CDMS were analyzed. OCGB detection showed a sensitivity of 91.4% and specificity of 94.1%. MRI-C had a sensitivity of 74.23% and specificity of 88.2%. The presence of either OCGB or MRI-C studied simultaneously showed a sensitivity of 97.1% and specificity of 88.2%. The presence of oligoclonal IgG bands is highly specific and sensitive for early prediction of conversion to multiple sclerosis. MRI criteria have a high specificity but less sensitivity. The simultaneous us...Continue Reading

Citations

Aug 8, 2008·Journal of Neurology·Stefan PresslauerWolfgang Hübl
Mar 3, 2009·Journal of Neurology·Ellen M MowryEmmanuelle Waubant
May 10, 2007·Current Neurology and Neuroscience Reports·Eric C Klawiter, Anne H Cross
Jul 12, 2008·The Neurologist·Catherine A Kernich
Jan 6, 2012·The Neurologist·Jane W Chan
Jan 30, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·N García-BarragánJ C Alvarez-Cermeño
Aug 19, 2011·Annals of Indian Academy of Neurology·M Alexander, J M K Murthy
Apr 17, 2013·Nature Reviews. Neurology·José C Álvarez-Cermeño, Luisa M Villar
Sep 2, 2008·Expert Review of Neurotherapeutics·José C Alvarez-CermeñoLuisa María Villar
Feb 26, 2013·Revue neurologique·A R ShatilaA Tourbah
Jan 3, 2016·Journal of the Neurological Sciences·José C Álvarez-CermeñoGema Rebolleda
Mar 29, 2011·Neurologic Clinics·Ellen M Mowry
May 16, 2009·Journal of Neuroimmunology·Luisa M VillarJosé C Alvarez-Cermeño
Sep 22, 2007·Journal of the Neurological Sciences·Luisa M VillarJosé C Alvarez-Cermeño
Sep 11, 2012·Journal of Neurochemistry·Myrthe RouwetteVeerle Somers
Mar 10, 2011·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Nov 13, 2010·Acta Neurologica Scandinavica·N SchäfflerC Heesen
Aug 3, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T F RuniaR Q Hintzen
Aug 29, 2006·Journal of Neuroimmunology·Jack Antel, Amit Bar-Or
Oct 18, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·L M VillarJ C Álvarez-Cermeño
Jan 8, 2015·Clinical and Experimental Immunology·E Rodríguez-MartínJ C Álvarez-Cermeño
Apr 15, 2015·Nature Reviews. Neurology·Jose C Álvarez-Cermeño, Luisa M Villar
May 6, 2015·Journal of the Neurological Sciences·Jagannadha R Avasarala
Jan 15, 2014·Medical Hypotheses·Mickael Bonnan
May 12, 2009·Neurobiology of Disease·Hayrettin TumaniUNKNOWN BioMS Study Group
Apr 14, 2012·Journal of Neuroimmunology·Eduardo BeltránBonaventura Casanova
Jun 28, 2011·Journal of Immunological Methods·V AbrairaL M Villar
Jul 21, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Luisa M VillarJosé C Alvarez-Cermeño
Sep 29, 2009·Journal of Neuroimmunology·Amer AwadOlaf Stuve
Aug 29, 2013·The Neurohospitalist·Jacqueline F Marcus, Emmanuelle L Waubant
Aug 26, 2011·Multiple Sclerosis : Clinical and Laboratory Research·M Gómez-MorenoA Ramos-González
Jul 16, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Almudena SantónJosé C Alvarez-Cermeño
Mar 26, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Luisa M VillarJosé C Alvarez-Cermeño
Mar 3, 2010·Multiple Sclerosis : Clinical and Laboratory Research·María Díaz-SánchezJulián Benito-León
Oct 14, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Ruth DobsonGavin Giovannoni
Mar 21, 2009·Multiple Sclerosis : Clinical and Laboratory Research·H ZéphirP Vermersch
Oct 22, 2013·Arquivos de neuro-psiquiatria·Sandro Luiz de Andrade MatasCarlos Augusto Senne Soares
Apr 9, 2008·Arquivos de neuro-psiquiatria·Ailton MeloAmit Bar-Or
Dec 24, 2009·Multiple Sclerosis : Clinical and Laboratory Research·Gauthier CalaisPatrick Hautecoeur
Dec 17, 2010·Multiple Sclerosis : Clinical and Laboratory Research·A G SkovJ L Frederiksen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.